Daniel Siniawski

445 total citations
40 papers, 281 citations indexed

About

Daniel Siniawski is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel Siniawski has authored 40 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 21 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel Siniawski's work include Lipoproteins and Cardiovascular Health (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Cardiovascular Health and Disease Prevention (8 papers). Daniel Siniawski is often cited by papers focused on Lipoproteins and Cardiovascular Health (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Cardiovascular Health and Disease Prevention (8 papers). Daniel Siniawski collaborates with scholars based in Argentina, Spain and United Kingdom. Daniel Siniawski's co-authors include Walter Massón, Martín Lobo, Graciela Molinero, Juan Patricio Nogueira, Arturo Cagide, Juan Krauss, René Valéro, Alfredo M. Rodriguez–Granillo, Mariano Giorgi and Pablo Corral and has published in prestigious journals such as Circulation, European Heart Journal and Lipids in Health and Disease.

In The Last Decade

Daniel Siniawski

37 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Siniawski Argentina 11 140 132 89 39 36 40 281
Yuan-Lin Guo China 13 203 1.4× 109 0.8× 139 1.6× 73 1.9× 36 1.0× 20 373
Dorota Taraszkiewicz France 13 125 0.9× 97 0.7× 159 1.8× 44 1.1× 26 0.7× 25 356
H.C. Geiss Germany 11 185 1.3× 154 1.2× 57 0.6× 56 1.4× 41 1.1× 12 316
Shivang Desai United States 7 101 0.7× 95 0.7× 84 0.9× 45 1.2× 40 1.1× 21 249
Marjet J.A.M. Braamskamp Netherlands 11 332 2.4× 146 1.1× 86 1.0× 26 0.7× 75 2.1× 23 452
Helle Kanstrup Denmark 10 131 0.9× 48 0.4× 110 1.2× 21 0.5× 19 0.5× 30 283
А. И. Ершова Russia 13 188 1.3× 93 0.7× 221 2.5× 95 2.4× 58 1.6× 98 487
Barbara Labrot Germany 5 242 1.7× 144 1.1× 143 1.6× 38 1.0× 66 1.8× 6 374
José María Cepeda Spain 11 111 0.8× 44 0.3× 139 1.6× 37 0.9× 40 1.1× 26 285
Ivan Pećin Croatia 9 125 0.9× 37 0.3× 99 1.1× 19 0.5× 17 0.5× 56 275

Countries citing papers authored by Daniel Siniawski

Since Specialization
Citations

This map shows the geographic impact of Daniel Siniawski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Siniawski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Siniawski more than expected).

Fields of papers citing papers by Daniel Siniawski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Siniawski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Siniawski. The network helps show where Daniel Siniawski may publish in the future.

Co-authorship network of co-authors of Daniel Siniawski

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Siniawski. A scholar is included among the top collaborators of Daniel Siniawski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Siniawski. Daniel Siniawski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siniawski, Daniel, Walter Massón, Patricia Sorroche, et al.. (2025). Niveles plasmáticos de apolipoproteínas en una población saludable de la Argentina: implicaciones en prevención cardiovascular. Revista Argentina de Cardiología. 78(2). 123–128.
2.
Massón, Walter, et al.. (2024). Inhibitors of apolipoprotein C3, triglyceride levels, and risk of pancreatitis: a systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders. 25(5). 817–825. 6 indexed citations
3.
Massón, Walter, et al.. (2024). Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 11. 1379189–1379189. 21 indexed citations
4.
Massón, Walter, et al.. (2024). Impact of Lipoprotein(a) Levels on Cardiovascular Risk Estimation. High Blood Pressure & Cardiovascular Prevention. 31(4). 381–388.
5.
Massón, Walter, et al.. (2023). Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system. Archives of Endocrinology and Metabolism. 67(3). 408–415. 4 indexed citations
6.
Siniawski, Daniel, et al.. (2023). Limitaciones de los puntajes de riesgo cardiovascular en prevención primaria ¿Una oportunidad para los moduladores de riesgo?. Revista Argentina de Cardiología. 109–116. 1 indexed citations
7.
Siniawski, Daniel, et al.. (2023). Residual cardiovascular risk, use of standard care treatments, and achievement of treatment goals in patients with cardiovascular disease. International Journal of Cardiology Cardiovascular Risk and Prevention. 18. 200198–200198. 10 indexed citations
8.
Massón, Walter, et al.. (2021). LDL-C Levels Below 55 mg/dl and Risk of Hemorrhagic Stroke: A Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases. 30(4). 105655–105655. 8 indexed citations
9.
Massón, Walter, et al.. (2020). Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression. Lipids in Health and Disease. 19(1). 111–111. 24 indexed citations
10.
Siniawski, Daniel, et al.. (2019). [Eligibility for the indication of PCSK9 inhibitors according to the recommendations of different scientific societies].. PubMed. 79(2). 104–110. 2 indexed citations
11.
Siniawski, Daniel, et al.. (2019). Elegibilidad para la indicación de inhibidores de PCSK9 según las recomendaciones de diferentes sociedades científicas. Medicina-buenos Aires. 104–110. 1 indexed citations
12.
Massón, Walter, et al.. (2019). Impact of Lipid-Lowering Therapy on Mortality According to the Baseline Non-HDL Cholesterol Level: A Meta-Analysis. High Blood Pressure & Cardiovascular Prevention. 26(4). 263–272. 9 indexed citations
13.
Massón, Walter, Martín Lobo, Daniel Siniawski, et al.. (2018). Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk. Diabetes & Metabolism. 44(6). 508–513. 40 indexed citations
14.
Massón, Walter, Daniel Siniawski, Martín Lobo, & Graciela Molinero. (2018). Lipid discordance and carotid plaque in obese patients in primary prevention. Endocrinología Diabetes y Nutrición (English ed ). 65(1). 39–44. 1 indexed citations
15.
Massón, Walter, Daniel Siniawski, Martín Lobo, & Graciela Molinero. (2017). Discordancia lipídica y placa carotídea en pacientes obesos en prevención primaria. Endocrinología Diabetes y Nutrición. 65(1). 39–44. 1 indexed citations
16.
Massón, Walter, Martín Lobo, Graciela Molinero, & Daniel Siniawski. (2017). Discordant Lipid Pattern and Carotid Atherosclerotic Plaque. Importance of Remnant Cholesterol. Arquivos Brasileiros de Cardiologia. 108(6). 526–532. 11 indexed citations
17.
Massón, Walter, et al.. (2015). Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression. Arquivos Brasileiros de Cardiologia. 105(1). 11–9. 12 indexed citations
18.
Siniawski, Daniel, Walter Massón, & César Belziti. (2014). Abstract 13041: An Updated Meta-Analysis and Meta-Regression of Niacin in Cardiovascular Prevention. Circulation. 130. 1 indexed citations
19.
20.
Siniawski, Daniel, et al.. (2011). Correlación entre las razones apolipoproteína B/apolipoproteína A1 y colesterol total/colesterol-HDL en una población saludable: ¿debería actualizarse el índice de Castelli?. Revista Argentina de Cardiología. 79(1). 0–0. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan-Lin Guo Breakdown of academic impact, for papers by Dorota Taraszkiewicz Breakdown of academic impact, for papers by H.C. Geiss Breakdown of academic impact, for papers by Shivang Desai Breakdown of academic impact, for papers by Marjet J.A.M. Braamskamp Breakdown of academic impact, for papers by Helle Kanstrup Breakdown of academic impact, for papers by А. И. Ершова Breakdown of academic impact, for papers by Barbara Labrot Breakdown of academic impact, for papers by José María Cepeda Breakdown of academic impact, for papers by Ivan Pećin
Rankless by CCL
2026